Financial Performance Review - Report on ICON

Aug 05, 2015, 09:15 ET from

NEW YORK, August 5, 2015 /PRNewswire/ --

ACI Association has initiated research coverage on ICON Public Limited Company (NASDAQ: ICLR). Select highlights from the internally released reports are being made available to the general public (included below), with access to the entirety of the research available to new members.

Today, membership is open to readers on a complementary basis at the following URL:  

Highlights from our ICLR Report include:

  • Second Quarter Results at a Glance - On Tuesday, July 28, 2015, ICON Public Limited Company (ICON) published results for the second quarter ended June 30, 2015. Net revenue of the drug development solutions and services provider stood at $388.7 million, as against $376 million in the same quarter last year, reflecting a growth of 3.4% YoY. In constant currency, net revenue grew by 9% YoY while recording a constant dollar organic growth of 4% YoY.  The Company recorded a 41% growth in income from operations to $68.1 million in Q2 2015 compared to $48.3 million in the year-ago period. Meanwhile, net income of ICON registered a strong growth of 44% at $58.6 million or 95 cents per share on a diluted basis. In Q2 2014, net income stood at $40.8 million or 64 cents per share on diluted basis.
  • Performance Review for H1 2015 - Net revenue witnessed a 7.1% jump to $776.9 million in H1 2015 from $725.7 million in the corresponding period a year earlier, representing 12.4% YoY constant currency growth and 6.7% constant dollar organic growth. Further, income from operations surged robustly by 48% to $134.8 million, forming 17.4% of net revenue. This compares to the Company's year-ago period's income from operations of $91.3 million which accounted for 12.6% of net revenue. ICON's net income for the period grew 49% YoY to $114.5 million compared to $77 million in the same period previous year. As per the release, the year to date earnings increased by 52% to $1.85 per share on a diluted basis, as against $1.22 per diluted share last year.
  • Revised Guidance for the Full Year - ICON has updated its guidance for the full year ending December 2015. The Company now expects the earnings to be in the range of $3.90 - $4.00, up from its previous guidance of $3.60 - $3.70. Additionally, the Company revised the revenue projections for the full-year due to lower than forecast backlog conversion during the quarter. Revenues are now projected to range from $1,570 - $1,600 million in the full year results, as against its previous forecasts of $1,600 - $1,650 million.

To find out how this influences our rating on ICON Public Limited Company, read the full report in its entirety here:


About ACI Association: 

Active Charter Investors Association ("ACI Association") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. ACI Association has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

ACI Association has not been compensated; directly or indirectly; for producing or publishing this document.


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the "CFA®"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the CFA® have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the CFA® (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.


ACI Association, the Author, the Reviewer and the CFA® (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither ACI Association nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit


ACI Association is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia. Do not send email to robottrap (at)

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.